Find the latest CBA, CBA stock market data. Get a full understanding of how CBA is performing with stock quotes and prices, as well as real-time news and analysis.
Ceiba Investments LimitedLSE:CBALondonOrdinary ShareGG00BFMDJH11ORD NPV Price Change% ChangeShare PriceShares TradedLast Trade 0.000.00%24.000.0000:00:00 Bid PriceOffer PriceHigh PriceLow PriceOpen Price 20.0028.0024.0024.0024.00 Industry SectorTurnoverProfitEPS - BasicPE RatioMarket Cap ...
Colony Bankcorp Inc.(CBAN) $17.030.27(1.61%) February 6, 2025 4:00 PMESTVolume: 81,819 USDNew York Stock ExchangeDelayed PriceMarket Closed Earnings High Target Price 19.50 Mean Target Price 19.00 Low Target Price 18.50 Standard Deviation: ...
CBAUF Peers Risk Short Interest - Shares Short 7.82M Days to Cover 999.99 24M Beta 0.44 Altman Z Score - Technicals Title 10D SMA 50D SMA 200D SMA Simple Moving Average 97.51 94.88 88.99 Last Price vs SMA -0.09% +2.68% +9.47%
The price of CBAN shares has decreased $0.02 since the market last closed. This is a 0.09% drop. Opened at $16.76. The stock opened $0.01 higher than its previous close.About CBAN Insights Learn Colony Bankcorp, Inc. is a bank holding company, which engages in the stockholder and inv...
CBA | Complete Commonwealth Bank of Australia stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Get Commonwealth Bank of Australia (CBA-AU:ASX) real-time stock quotes, news, price and financial information from CNBC.
CANF Stock Alert: The Liver Cancer News Catapulting Can-Fite BioPharma Shares Higher Today Dec. 20, 2021 at 12:08 p.m. ETon InvestorPlace.com Analysts Are Bullish on These Healthcare Stocks: Can-Fite BioPharma (CANF), CymaBay Therapeutics (CBAY) ...
41 followers ACBA is defunctsince May 24, 2024.Defunct Summary ACBA Analysis Merger Arbitrage Mondays - Landmark Infrastructure Partners Acquired By Its General Partner At A Significant Premium ETFs Holding ACBA Sorry, this data cannot be displayed at the moment....
Shares Outstanding, K1,672,070 Annual Sales, $27,309 M Annual Income, $9,394 M EBIT $N/A EBITDA $N/A 60-Month BetaN/A Price/Sales10.64 Price/Cash FlowN/A Price/Book3.72 Price/Earnings ttm28.91 Earnings Per Share ttm5.58 Most Recent EarningsN/A on N/A ...